Thomas Anthony D’amico

Thomas Anthony D’amico's AcademicInfluence.com Rankings

Medical

#2330

World Rank

#2747

Historical Rank

Surgery

#185

World Rank

#233

Historical Rank

medical Degrees

Thomas Anthony D’amico

Philosophy

#6784

World Rank

#9882

Historical Rank

Logic

#3896

World Rank

#5122

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Thomas Anthony D’amico Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Thomas Anthony D’amico's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Non-small cell lung cancer clinical practice guidelines in oncology. (2006) (1010)
Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology (2017) (805)
Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. (2010) (674)
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. (2019) (576)
Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology (2016) (544)
Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study. (2007) (516)
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020. (2019) (490)
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. (2021) (423)
Reducing hospital morbidity and mortality following esophagectomy. (2004) (417)
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018. (2018) (411)
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. (2017) (411)
Esophageal and esophagogastric junction cancers, version 1.2015. (2015) (396)
Thoracoscopic Lobectomy Is a Safe and Versatile Procedure: Experience With 500 Consecutive Patients (2006) (391)
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016. (2016) (382)
Non-Small Cell Lung Cancer, Version 6.2015. (2015) (373)
Gastric Cancer, Version 2.2013 (2013) (364)
Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. (2016) (343)
Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy. (2009) (320)
Non-small cell lung cancer, version 2.2013: Featured updates to the NCCN guidelines (2013) (313)
Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. (2013) (306)
Non-small cell lung cancer. (2012) (277)
Esophageal and esophagogastric junction cancers. (2011) (276)
Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer. (2007) (275)
Non-small cell lung cancer. Clinical practice guidelines in oncology. (2004) (269)
Non-small cell lung cancer, version 2.2013. (2013) (234)
A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers. (1999) (232)
Local recurrence after surgery for early stage lung cancer (2009) (214)
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. (2022) (203)
Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. (2006) (202)
Thoracoscopic Lobectomy Has Increasing Benefit in Patients With Poor Pulmonary Function: A Society of Thoracic Surgeons Database Analysis (2012) (199)
Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry (2016) (195)
Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers. (2013) (184)
Risk factors for atrial fibrillation after lung cancer surgery: analysis of the Society of Thoracic Surgeons general thoracic surgery database. (2010) (184)
Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. (2007) (183)
Acute Lung Injury and Acute Respiratory Distress Syndrome After Pulmonary Resection (2004) (180)
Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. (2009) (178)
Video-assisted thoracoscopic surgery lobectomy at 20 years: a consensus statement. (2014) (175)
A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. (2003) (163)
Non-small cell lung cancer, version 1.2015. (2014) (154)
Pulmonary segmentectomy by thoracotomy or thoracoscopy: reduced hospital length of stay with a minimally-invasive approach. (2007) (151)
Gastric cancer. Clinical practice guidelines in oncology. (2006) (151)
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. (2022) (147)
Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer. (2016) (144)
Thoracoscopic lobectomy: a safe and effective strategy for patients with stage I lung cancer. (2002) (140)
Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis. (2016) (127)
Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy. (2010) (124)
Risk factors for morbidity after lobectomy for lung cancer in elderly patients. (2009) (124)
Use and Outcomes of Minimally Invasive Lobectomy for Stage I Non-Small Cell Lung Cancer in the National Cancer Data Base. (2016) (118)
Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database. (2015) (116)
Efficacy of mediastinal lymph node dissection during lobectomy for lung cancer by thoracoscopy and thoracotomy. (2011) (114)
Efficacy of Single-dose, Multilevel Paravertebral Nerve Blockade for Analgesia after Thoracoscopic Procedures (2006) (113)
Outcomes of video-assisted thoracoscopic decortication. (2010) (107)
Outcomes of tracheobronchial stents in patients with malignant airway disease. (2005) (107)
Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer. (2012) (104)
Non-small cell lung cancer. (2010) (103)
A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer (2017) (103)
Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients. (2000) (99)
Troubleshooting video-assisted thoracic surgery lobectomy. (2005) (91)
The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer. (2001) (89)
Optimal management of malignant pleural effusions (results of CALGB 30102). (2012) (88)
Molecular biologic substaging of stage I lung cancer according to gender and histology. (2000) (87)
Tumor marker expression is predictive of survival in patients with esophageal cancer. (2001) (85)
Thoracoscopic lobectomy: a safe and effective strategy for patients receiving induction therapy for non-small cell lung cancer. (2006) (84)
Predicting the sites of metastases from lung cancer using molecular biologic markers. (2001) (84)
Contraindications of video-assisted thoracoscopic surgical lobectomy and determinants of conversion to open. (2013) (83)
Smoking status and survival in the national comprehensive cancer network non–small cell lung cancer cohort (2013) (81)
Thoracoscopic approach to lobectomy for lung cancer does not compromise oncologic efficacy. (2014) (80)
Thoracoscopic segmentectomy for lung cancer. (2012) (80)
Molecular biology of esophageal cancer. (2000) (80)
Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle (2011) (78)
Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer. (2017) (77)
NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016. (2016) (76)
Lymphovascular Invasion in Non–Small-Cell Lung Cancer: Implications for Staging and Adjuvant Therapy (2012) (75)
Thoracoscopic lobectomy: the gold standard for early-stage lung cancer? (2010) (74)
The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement. (2012) (72)
Esophageal cancer. Clinical practice guidelines in oncology. (2006) (72)
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. (2021) (70)
Intraoperative Sentinel Node Mapping with Technitium-99 in Lung Cancer: Results of CALGB 140203 Multicenter Phase II Trial (2009) (66)
Induction Therapy Does Not Improve Survival for Clinical Stage T2N0 Esophageal Cancer (2014) (66)
Don't look back. (2017) (66)
Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States. (2016) (65)
A model for morbidity after lung resection in octogenarians. (2011) (64)
Quality of life outcomes are equivalent after lobectomy in the elderly. (2008) (63)
Outcomes after surgery for esophageal cancer. (2007) (63)
Primary chest wall tumors. (2010) (62)
Desensitization of myocardial beta-adrenergic receptors and deterioration of left ventricular function after brain death. (1995) (61)
Issues with implementing a high‐quality lung cancer screening program (2014) (60)
Measurement of chemoresistance markers in patients with stage III non-small cell lung cancer: a novel approach for patient selection. (2003) (60)
Intraoperative Magnesium Administration Does Not Improve Neurocognitive Function After Cardiac Surgery (2013) (60)
Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer. (2016) (58)
A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia. (2010) (58)
Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma (2017) (57)
Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008. (2012) (57)
Effects of triiodothyronine and vasopressin on cardiac function and myocardial blood flow after brain death. (1993) (55)
In situ detection of nuclear atypia in Barrett's esophagus by using angle-resolved low-coherence interferometry. (2007) (54)
Thymomas and thymic carcinomas (2013) (54)
A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer (2019) (54)
Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis. (2016) (54)
Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy. (2012) (54)
Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer (2017) (53)
Cognitive decline after major noncardiac operations: a preliminary prospective study. (1999) (52)
Review and Recent Development of Angle-Resolved Low-Coherence Interferometry for Detection of Precancerous Cells in Human Esophageal Epithelium (2008) (52)
VATS versus open surgery for lung cancer resection: moving toward a minimally invasive approach. (2015) (51)
Feasibility of hybrid thoracoscopic lobectomy and en-bloc chest wall resection. (2012) (51)
Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab (2017) (51)
An inexpensive, reproducible tissue simulator for teaching thoracoscopic lobectomy. (2010) (50)
Low morbidity and mortality for bronchoplastic procedures with and without induction therapy. (2005) (50)
A cost-minimisation analysis of lobectomy: thoracoscopic versus posterolateral thoracotomy. (2010) (50)
Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology. (2013) (50)
Impact of T status and N status on perioperative outcomes after thoracoscopic lobectomy for lung cancer. (2013) (49)
Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer. (2009) (48)
Pathologic Nodal Status Predicts Disease-Free Survival After Neoadjuvant Chemoradiation for Gastroesophageal Junction Carcinoma (2006) (48)
A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non–small cell lung cancer (2017) (47)
Respiratory complications after esophagectomy. (2006) (46)
Surgical management of pulmonary metastases. (2009) (46)
Radiation therapy at the end of life in patients with incurable nonsmall cell lung cancer (2012) (46)
Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe (2017) (45)
Smoking history predicts for increased risk of second primary lung cancer: A comprehensive analysis (2015) (45)
Sex differences in early outcomes after lung cancer resection: analysis of the Society of Thoracic Surgeons General Thoracic Database. (2014) (45)
Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer. (2017) (44)
Uniportal VATS-a new era in lung cancer surgery. (2015) (44)
Comparative effectiveness of stereotactic radiosurgery versus whole‐brain radiation therapy for patients with brain metastases from breast or non–small cell lung cancer (2016) (43)
Modern impact of video assisted thoracic surgery. (2014) (42)
Defining the role of adjuvant chemotherapy after lobectomy for typical bronchopulmonary carcinoid tumors. (2015) (41)
Surgical techniques to avoid parenchymal injury during lung resection (fissureless lobectomy). (2010) (40)
Personalized targeted therapy for esophageal squamous cell carcinoma. (2015) (39)
How Well Does the New Lung Cancer Staging System Predict for Local/Regional Recurrence After Surgery?: A Comparison of the TNM 6 and 7 Systems (2011) (39)
Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer. (2015) (37)
Thoracoscopic segmentectomy: technical considerations and outcomes. (2008) (37)
The Optimal Treatment for Stage IIIA-N2 Non-Small Cell Lung Cancer: A Network Meta-Analysis. (2019) (37)
Personalized and targeted therapy of esophageal squamous cell carcinoma: an update (2016) (35)
Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer. (2017) (35)
Validation of a thoracoscopic lobectomy simulator. (2012) (35)
Long-Term Outcomes of Lobectomy for Non-Small Cell Lung Cancer After Definitive Radiation Treatment. (2015) (35)
Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage I non-small cell lung cancer. (2014) (34)
European guidelines on structure and qualification of general thoracic surgery. (2014) (34)
Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer. (2007) (33)
Molecular biologic staging of lung cancer. (2008) (33)
Perioperative management of patients on clopidogrel (Plavix) undergoing major lung resection. (2011) (33)
Variability in the Treatment of Elderly Patients with Stage IIIA (N2) Non–Small-Cell Lung Cancer (2013) (33)
Thoracoscopic versus robotic approaches: advantages and disadvantages. (2014) (33)
A National Analysis of Short-term Outcomes and Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Clinical Stage II Non-Small-Cell Lung Cancer (2019) (32)
Long-term outcomes of thoracoscopic lobectomy. (2008) (32)
Open, thoracoscopic and robotic segmentectomy for lung cancer. (2014) (32)
The impact of tumor size on the association of the extent of lymph node resection and survival in clinical stage I non-small cell lung cancer. (2015) (32)
Outcomes after surgical management of synchronous bilateral primary lung cancers. (2012) (32)
Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis. (2018) (31)
Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies. (2002) (31)
Mckeown esophagogastrectomy. (2014) (29)
The prognostic importance of the number of dissected lymph nodes after induction chemoradiotherapy for esophageal cancer. (2015) (29)
Quantifying the safety benefits of wedge resection: a society of thoracic surgery database propensity-matched analysis. (2014) (29)
Minimally Invasive Thoracic Surgery 3.0: Lessons Learned From the History of Lung Cancer Surgery (2018) (29)
Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer. (2016) (28)
Treatment Modalities for T1N0 Esophageal Cancers: A Comparative Analysis of Local Therapy Versus Surgical Resection (2013) (28)
Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer. (2021) (28)
Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer. (2017) (28)
Adjuvant Therapy for Patients with Early Large Cell Lung Neuroendocrine Cancer: A National Analysis. (2019) (27)
Gastric Cancer Clinical Practice Guidelines. (2006) (27)
Esophageal Cancer Clinical Practice Guidelines. (2006) (27)
The impact of pulmonary hypertension on morbidity and mortality following major lung resection. (2013) (27)
Thoracoscopic Lobectomy for Non-small Cell Lung Cancer. (2016) (27)
A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer. (2016) (27)
Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: results of CALGB Protocol 39803. (2013) (26)
A national analysis of open versus minimally invasive thymectomy for stage I to III thymoma. (2019) (25)
First-line systemic therapy practice patterns and concordance with NCCN guidelines for patients diagnosed with metastatic NSCLC treated at NCCN institutions. (2012) (25)
Learning curve for uniportal video-assisted thoracoscopic surgery lobectomy-results from 120 consecutive patients. (2018) (25)
Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer. (2015) (24)
Intrathoracic Desmoid Tumor: Brief Report and Review of Literature (2008) (24)
The role of radiation therapy in resected T2 N0 esophageal cancer: a population-based analysis. (2013) (24)
"Anatomically-correct" dosimetric parameters may be better predictors for esophageal toxicity than are traditional CT-based metrics. (2005) (24)
Modified uniportal video-assisted thoracoscopic lobectomy: Duke approach. (2014) (24)
Thoracoscopic lobectomy: evolving and improving. (2006) (24)
Adjuvant Chemotherapy Is Associated with Improved Survival after Esophagectomy without Induction Therapy for Node-Positive Adenocarcinoma (2015) (24)
Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival. (2014) (23)
Robotics in thoracic surgery: applications and outcomes. (2006) (23)
Angiogenesis in non-small cell lung cancer. (2004) (23)
DIAGNOSIS AND STAGING OF LUNG CANCER (2008) (23)
Local recurrence after surgery for non-small cell lung cancer: a recursive partitioning analysis of multi-institutional data. (2013) (23)
Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008. (2014) (23)
Patient Preferences in Treatment Choices for Early-Stage Lung Cancer. (2016) (22)
Oncologic Equivalence of Minimally Invasive Lobectomy: The Scientific and Practical Arguments. (2018) (22)
Surgical techniques and results of the pulmonary artery reconstruction for patients with central non-small cell lung cancer (2013) (22)
Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer. (2016) (22)
Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagus (2019) (22)
Prospective phase II trial of pre-resection thoracoscopic (VATS) restaging following neoadjuvant therapy for IIIA(N2) non-small cell lung cancer (NSCLC): Results of CALGB 39803 (2005) (22)
Outcomes for Surgery in Large Cell Lung Neuroendocrine Cancer. (2019) (22)
The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients (2017) (21)
Gastric cancer. (2010) (21)
Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection. (2006) (21)
Benefit of Adjuvant Chemotherapy After Resection of Stage II (T1-2N1M0) Non-Small Cell Lung Cancer in Elderly Patients (2015) (21)
18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery (2018) (21)
Surgical treatment for early stage non-small cell lung cancer. (2018) (20)
Outcomes after treatment of 17,378 patients with locally advanced (T3N0-2) non-small-cell lung cancer. (2015) (19)
Patterns of recurrence after trimodality therapy for esophageal cancer (2014) (19)
Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC. (2018) (19)
Intravenous Lidocaine Does Not Improve Neurologic Outcomes after Cardiac Surgery: A Randomized Controlled Trial (2019) (19)
Use of amiodarone after major lung resection. (2014) (19)
Targeted therapy for non-small cell lung cancer. (2005) (19)
Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing? (2017) (19)
Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery. (2019) (19)
The impact of pre-radiotherapy surgery on radiation-induced lung injury. (2005) (19)
Esophageal cancer in elderly patients: a population-based study. (2017) (19)
Variation in Definitive Therapy for Localized Non-Small Cell Lung Cancer Among National Comprehensive Cancer Network Institutions. (2016) (18)
A randomized, double blind, placebo controlled clinical trial of the preoperative use of ketamine for reducing inflammation and pain after thoracic surgery (2011) (18)
Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study. (2014) (18)
Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors. (2017) (18)
The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study. (2019) (18)
Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer. (2015) (17)
"Reality surgery"--a research ethics perspective on the live broadcast of surgical procedures. (2011) (17)
Impact of positive margins and radiation after tracheal adenoid cystic carcinoma resection on survival. (2020) (17)
Does pneumonectomy have a role in the treatment of stage IIIA non-small cell lung cancer? (2013) (17)
Survival in the elderly after pneumonectomy for early-stage non-small cell lung cancer: a comparison with nonoperative management. (2014) (17)
Molecular biologic substaging of non-small cell lung cancer. (2002) (17)
Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer. (2011) (16)
Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer (2020) (16)
Adjuvant Chemotherapy After Lobectomy for T1-2N0 Non-Small Cell Lung Cancer: Are the Guidelines Supported? (2015) (16)
Patterns of Treatment and Outcomes for Definitive Therapy of Early Stage Non-Small Cell Lung Cancer. (2017) (16)
Radiofrequency ablation for primary lung cancer and pulmonary metastases. (2008) (16)
Cardiothoracic surgeons in pandemics: Ethical considerations (2020) (15)
The immunotherapeutic landscape in non-small cell lung cancer and its surgical horizons. (2019) (15)
Preoperative radiation therapy and chemotherapy for pulmonary blastoma: a case report. (2010) (15)
Efficacy of mediastinal lymph node dissection during thoracoscopic lobectomy. (2012) (14)
Minimally Invasive Approaches Do Not Compromise Outcomes for Pneumonectomy: A Comparison Using the National Cancer Database (2018) (14)
How I Teach a Thoracoscopic Lobectomy. (2016) (14)
Videothoracoscopic mediastinal lymphadenectomy. (2010) (14)
Pulmonary arterial impedance after single lung transplantation. (1992) (14)
Radical Minimally Invasive Surgery After Immuno-chemotherapy in Initially-unresectable Stage IIIB Non-small cell Lung Cancer (2021) (13)
Thoracoscopic left upper lobectomy in patients with internal mammary artery coronary bypass grafts. (2014) (13)
Needs assessment for an errors-based curriculum on thoracoscopic lobectomy. (2012) (13)
A protocol to reduce self-reported pain scores and adverse events following lumbar punctures in older adults (2020) (13)
A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma. (2007) (13)
Right-Sided Versus Left-Sided Pneumonectomy After Induction Therapy for Non-Small Cell Lung Cancer. (2019) (13)
Complications of thoracoscopic pulmonary resection. (2007) (13)
The Role of Neoadjuvant Chemotherapy in Patients with Resectable Malignant Pleural Mesothelioma - An Institutional and National Analysis. (2020) (12)
Racial and Ethnic Differences in Lung Cancer Surgical Stage: An STS Database Study (2015) (12)
No heroic measures: how soon is too soon to stop? (2009) (12)
The Effect of Tumor Size and Histology on Outcomes Following Segmentectomy vs. Lobectomy for Clinically Node-negative Non-small Cell Lung Cancer. (2020) (12)
Surgical management of congenital pulmonary malformations after the first decade of life. (2014) (12)
VATS lobectomy facilitates the delivery of adjuvant docetaxel-carboplatin chemotherapy in patients with non-small cell lung cancer. (2016) (12)
A Minimally Invasive Approach to Lobectomy After Induction Therapy Does Not Compromise Survival. (2019) (12)
Improving lung cancer outcomes by improving the quality of surgical care. (2015) (12)
Esophageal cancer. (2020) (12)
Operative techniques in early-stage lung cancer. (2010) (12)
Extensive invasion of the left atrium by lung cancer. (2013) (12)
Milestones in thoracic surgery (2018) (11)
Less is more: a shift in the surgical approach to non-small-cell lung cancer. (2016) (11)
The effect of extent of resection on outcomes in patients with limited stage small cell lung cancer. (2020) (11)
Thoracoscopic lobectomy for the management of non-small cell lung cancer (2008) (11)
Transhiatal esophagogastrectomy for an isolated ovarian cancer metastasis to the esophagus. (2004) (10)
Quality Measurement in Cancer Care: A Review and Endorsement of High-Impact Measures and Concepts. (2020) (10)
The Oldest Old: A National Analysis of Outcomes for Patients 90 Years or Older With Lung Cancer. (2019) (10)
The effect of age on survival after endoscopic resection versus surgery for T1a esophageal cancer. (2019) (10)
Effect of Lymph Node Assessment on Outcomes in Surgery for Limited Stage Small Cell Lung Cancer. (2020) (10)
Differential prognostic significance of extralobar and intralobar nodal metastases in patients with surgically resected stage II non-small cell lung cancer. (2014) (10)
Challenging cases: thoracoscopic lobectomy with chest wall resection and sleeve lobectomy-Duke experience. (2014) (10)
Is radiation without surgery the adequate therapy for potentially resectable esophageal squamous cell carcinoma? An analysis using the Surveillance Epidemiology, and End Results registry from 1998 to 2008 (2012) (10)
Impact of Pretreatment Imaging on Survival of Esophagectomy After Induction Therapy for Esophageal Cancer: Who Should be Given the Benefit of the Doubt? (2015) (10)
Estimating the Impact of Extended Delay to Surgery for Stage I Non-small-cell Lung Cancer on Survival (2021) (10)
The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-negative Esophageal Adenocarcinoma (2020) (9)
Technique of Thoracoscopic Segmentectomy (2008) (9)
Framing for success: nocebo effects in thoracic surgery. (2013) (9)
Defining and improving postoperative care. (2014) (9)
Controversial issues regarding the use of induction chemotherapy for lung cancer. (2005) (9)
Comparison of in-dwelling catheters and talc pleurodesis in the management of malignant pleural effusions. (2010) (9)
Giant thoracic liposarcoma treated with induction chemotherapy followed by surgical resection. (2009) (9)
Technique of thoracoscopic basilar segmentectomy. (2011) (9)
Effects of cardiac glycosides on myocardial function and energetics in conscious dogs. (1990) (8)
P2.04-89 Neoadjuvant Pembrolizumab in Early Stage Non-Small Cell Lung Cancer (NSCLC): Toxicity, Efficacy, and Surgical Outcomes (2019) (8)
Spontaneous herniation of the lung and diaphragm treated with surgical repair. (2015) (8)
Diabetes mellitus: A significant co‐morbidity in the setting of lung cancer? (2013) (8)
A National Analysis of Minimally Invasive vs Open Segmentectomy for Stage IA Non-small-cell Lung Cancer. (2020) (8)
Thoracic Oncology (2nd ed.) (1996) (8)
Troubleshooting thoracoscopic anterior mediastinal surgery: lessons learned from thoracoscopic lobectomy. (2015) (8)
Small Cell Lung Cancer, Version 2.2022 (2021) (8)
Challenging 30-day mortality as a site-specific quality metric in non-small cell lung cancer. (2019) (8)
Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma. (2016) (8)
National Comprehensive Cancer Network Guidelines: Who Makes Them? What Are They? Why Are They Important? (2020) (7)
Ethics in cardiothoracic surgery: a survey of surgeons' views. (2010) (7)
Training Assistants Improves the Process of Adoption of Video-Assisted Thoracic Surgery Lobectomy. (2015) (7)
Malignant melanoma presenting as a mediastinal mass. (1999) (7)
Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients. (2016) (7)
Detection of occult N2 disease with molecular techniques. (2008) (7)
Effect of time to surgery on outcomes in stage I esophageal adenocarcinoma. (2019) (7)
Molecular staging of lung and esophageal cancer. (2002) (7)
Molecular biologic staging of esophageal cancer. (2006) (7)
The best that surgery has to offer. (2013) (7)
Adjuvant chemotherapy after resection of N1 non-small cell lung cancer: differential impact of new evidence on physician and patient decisions. (2015) (7)
Surgery versus SABR for resectable non-small-cell lung cancer. (2015) (6)
Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non-small cell lung cancer. (2019) (6)
Video assisted transaxillary first rib resection in treatment of thoracic outlet syndrome (TOS). (2016) (6)
The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma (2020) (6)
Malignant pleural mesothelioma. (2015) (6)
Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy. (2015) (6)
Patterns of Failure After Surgery for Non–Small‐cell Lung Cancer Invading the Chest Wall (2017) (6)
Thoracoscopic lobectomy after induction therapy-a paradigm shift? (2017) (6)
A 10-gene progenitor cell signature predicts poor prognosis in lung adenocarcinoma. (2011) (6)
Thymic malignancies. (2010) (6)
Cardiothoracic Surgeons in Pandemics: Ethical Considerations (2020) (6)
Myxoid liposarcoma of the supraclavicular fossa. (2000) (6)
Atlas of Uniportal Video Assisted Thoracic Surgery (2019) (6)
NCCN Non – Small Cell Lung Cancer Clinical Practice Guidelines in Oncology (2010) (6)
Impact of Age on Surgical Outcomes for Locally Advanced Esophageal Cancer. (2020) (6)
Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer. (2016) (6)
Accuracy of FDG-PET to diagnose lung cancer in the ACOSOG Z4031 trial. (2012) (5)
Modified uniportal video-assisted thoracoscopic surgery (VATS). (2016) (5)
Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials. (2016) (5)
Tumor Acquisition for Biomarker Research in Lung Cancer (2014) (5)
The influence of adjuvant therapy on survival in patients with indeterminate margins following surgery for non-small cell lung cancer. (2019) (5)
Early feeding after esophagectomy may be too early. (2016) (5)
Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant? (2013) (5)
Stability of the beta-adrenergic receptor/adenylyl cyclase pathway of pediatric myocardium after brain death. (1994) (5)
Patterns of Use of Induction Therapy for T2N0 Esophageal Cancer. (2020) (5)
Outcomes after pneumonectomy for benign disease: the impact of urgent resection. (2014) (5)
Interinstitutional Variation in Management Decisions for Treatment of 4 Common Types of CancerA Multi-institutional Cohort StudyInterinstitutional Variation in Cancer Management Decisions (2014) (5)
Dosimetric parameters derived from anatomically-correct esophageal contours are better predictors for esophageal toxicity than are those based on standard “CT-only-defined” contours (2004) (5)
Segmentectomy and Lung Cancer: Why, When, How, and How Good? (2017) (5)
Anatomic thoracoscopic segmentectomy for early-stage lung cancer. (2017) (4)
Value of intraoperative pleural lavage in staging non-small cell lung cancer. (2004) (4)
Impact of Surveillance After Lobectomy for Lung Cancer on Disease Detection and Survival. (2020) (4)
Laparoscopic Instrumentation and Basic Techniques (1996) (4)
Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults (2021) (4)
Location of the Tumor is a "Central" Predictor of Nodal (N1) Upstaging. (2016) (4)
Perioperative Outcomes and 5-year Survival After Open versus Thoracoscopic Sleeve Resection for Lung Cancer. (2020) (4)
General thoracic surgical training in North America: Contrasting general thoracic surgery residencies in Canada and the United States (2018) (4)
Higher Use of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer. (2018) (3)
Surgery is Associated with Survival Benefit in T4a Esophageal Adenocarcinoma: A National Analysis. (2019) (3)
Complications of Mediastinal Surgery (2007) (3)
Adult Tracheoesophageal Fistula: A Multidisciplinary Approach (2008) (3)
Tumor Size, Histology, and Survival After Stereotactic Ablative Radiotherapy and Sublobar Resection in Node-negative Non-small Cell Lung Cancer (2021) (3)
Management of pulmonary arterial bleeding in the post induction setting. (2016) (3)
Proteomic analysis for detection of NSCLC: Results of ACOSOG Z4031. (2011) (3)
Improving outcomes after esophagectomy: the importance of preventing postoperative pneumonia. (2011) (3)
Utilization Trends and Volume-outcomes Relationship of Endoscopic Resection for Early Stage Esophageal Cancer (2021) (3)
Surgery versus optimal medical management of early-stage small cell lung cancer. (2016) (3)
Local control without resection. (2003) (3)
General Thoracic Surgery, 7th Edition, Thomas W. Shields (Ed.), et al.. Lippincott Williams & Wilkins, Philadelphia (2009), 2,552 pp, illustrated, $379.00, ISBN: 0-7817-7982-0 (2010) (3)
Historical perspectives of The American Association for Thoracic Surgery: Evarts A. Graham (1883-1957). (2011) (3)
Gene therapy for lung cancer. (2000) (3)
The biomolecular era for thoracic surgeons: the example of the ESTS Biology Club. (2014) (3)
Molecular staging and the selection of therapy for non-small cell lung cancer. (2005) (3)
Undoing the gaps in quality, cost, and value. (2017) (3)
Uniportal lobectomy and segmentectomy-is it for all? (2017) (2)
Historical perspectives of The American Association for Thoracic Surgery: James Lewis Cox (1942-). (2015) (2)
Lung volume reduction surgery for the management of refractory dyspnea in chronic obstructive pulmonary disease (2009) (2)
Dosimetric parameters predictive for esophageal injury (2003) (2)
Commentary: Surgery for small cell lung cancer: This is the way. (2020) (2)
Partial anomalous pulmonary venous return to azygos vein with absent segmental bronchus. (2013) (2)
"Early" thoracic duct ligation for chylothorax after esophagectomy means "now". (2016) (2)
The History of Duke Thoracic Surgery. (2015) (2)
Surgery for esophageal cancer. (2008) (2)
Suitability of the lumbar test dose for the thoracic epidural space. (2006) (2)
Multidisciplinary approach to treatment of radiation-induced chest wall sarcoma (2016) (2)
Editorial comment: Clinical pathways: mediastinoscopy and mediastinal lymph node dissection. (2011) (2)
Comment on "Early Feeding After Esophagectomy: Show Must Go On". (2019) (2)
Incorporating research into thoracic surgery practice. (2011) (2)
Unethical studies on transplantation in cardiothoracic surgery journals. (2021) (2)
The Role of Adjuvant Therapy in Patients With Margin-Positive (R1) Esophagectomy: A National Analysis. (2020) (2)
Survival after radiation for stage I and II non-small cell lung cancer with positive margins. (2018) (2)
Abstract LB-296: FDG-PET avidity negatively impacts survival in pStage I NSCLC in the ACOSOG Z4031 trial. (2013) (2)
Molecular biologic substaging of stage I NSCLC through immunohistochemistry performed on formalin-fixed, paraffin-embedded tissue. (2003) (2)
Thoracoscopic diaphragm plication. (2015) (2)
Resection for Lung Cancer Thoracoscopic Lobectomy Facilitates the Delivery of Chemotherapy after (2007) (1)
Surgical excision for mediastinal synovial sarcoma with limited response to chemoradiotherapy. (2014) (1)
Early Feeding After Esophagectomy: Show Must Go On (2018) (1)
Improved tolerance of the pediatric myocardium to brain death. (1993) (1)
The handbook of surgical intensive care : practices of the surgical residents at Duke University Medical Center (1995) (1)
The efficiency of pulmonary blood transport following single lung transplantation. (1993) (1)
Dual portal thoracoscopic left upper lobectomy with sharp division of the left upper lobe bronchus for the management of difficult lymphadenopathy complicating isolation of the truncus anterior pulmonary arterial branch (2016) (1)
Positron emission tomography in esophageal cancer. (2008) (1)
The Role of Minimally Invasive Surgery (2018) (1)
P1.03-048 A Structured Lung Cancer Screening Program Facilitates Patient and Provider Compliance: Topic: Screening (2017) (1)
The Effect of Center Esophagectomy Volume on Outcomes in Clinical Stage I-III Esophageal Cancer. (2022) (1)
Unethical Studies on Transplantation in Cardiothoracic Surgery Journals. (2021) (1)
Pericardial Procedures (2020) (1)
Historical perspectives of The American Association for Thoracic Surgery: David C. Sabiston, Jr (1924-2009). (2015) (1)
Erratum: Smoking status and survival in the national comprehensive cancer network nonsmall cell lung cancer cohort (Cancer (doi: 10.1002/cncr.27824)) (2013) (1)
Complications after Pulmonary Resection: Lobectomy and Pneumonectomy (2009) (1)
Historical perspectives of The American Association for Thoracic Surgery: G. Alexander Patterson. (2014) (1)
The role of radiation therapy in resected T2N0 esophageal cancer: A population-based analysis (2013) (1)
The Impact of Extended Delayed Surgery for Indolent Lung Cancer or Part-Solid Ground Glass Nodules (2021) (1)
Dual portal thoracoscopic left upper lobectomy with suture repair of pulmonary arterial injury following achievement of proximal vascular control (2016) (1)
The Effect of Timing of Adjuvant Therapy on Survival following Esophagectomy. (2020) (1)
Right Upper Lobe Sleeve Resection (1998) (1)
E18. Thoracoscopic lobectomy (syllabus) (2005) (1)
A young man with progressive esophageal neoplasms. (2018) (1)
Aggressive end-of-life (EOL) chemotherapy (CT) use in metastatic non-small cell lung cancer (mNSCLC): A National Comprehensive Cancer Network (NCCN) outcomes database analysis. (2011) (1)
Thoracoscopic pneumonectomy in management of histoplasmosis and fibrosing mediastinitis. (2014) (1)
Reply to Perna et al. (2016) (1)
Reply to D.A. Palma. (2017) (1)
Modern Management of Pulmonary Metastases. (2016) (1)
Get it right the first time. (2017) (1)
NCCN Non – Small Cell Lung Cancer , Version 1 . 2015 Clinical Practice Guidelines in Oncology (2014) (1)
Less is sometimes less. (2018) (1)
Retrospective analysis of the impact of age on overall survival in patients with non-small cell lung cancer. (2012) (1)
Does the revised TNM staging system for lung cancer better estimate actuarial rates of local/regional recurrence after surgery? (2010) (1)
Weighing the relative importance of short-term versus long-term outcomes when comparing surgery versus stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer. (2018) (1)
Factors influencing outcome after pulmonary resection for colorectal cancer (CRC) metastases in the current era (2008) (1)
VATS Versus Thoracotomy for Major Lung Resection After Induction Therapy (2011) (1)
Adjuvant chemotherapy for non-small cell lung cancer. (2005) (1)
A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma. (2008) (1)
Lung transplantation at Duke University Medical Center. (1998) (1)
Historical perspectives of The American Association for Thoracic Surgery: Hiram T. Langston (1912-1992). (2012) (1)
Molecular Oncology: Esophageal cancer (2013) (0)
MS06.03 Pathologic Staging: Operative Events (2019) (0)
Impact of Time to Endoscopic Resection on Outcomes for Stage I Esophageal Adenocarcinoma. (2021) (0)
O-027PERFORMING SUBLOBAR RESECTION INSTEAD OF LOBECTOMY COMPROMISES THE SURVIVAL OF STAGE I NON-SMALL CELL LUNG CANCER PATIENTS 80 YEARS OF AGE AND OLDER (2015) (0)
2147 : Neoadjuvant Chemoradiotherapy for Operable Esophageal Cancer: Is Paclitaxel Necessary? (2006) (0)
MA 19.09 The Role of Neoadjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma (2017) (0)
Reply: The boat, the sword, and the opacity of Chinese transplant data. (2022) (0)
Outcomes after treatment of resectable, node-negative esophageal cancer: A risk-adjusted analysis of the Surveillance, Epidemiology, and End Results registry. (2012) (0)
Novel alterations of the adaptor protein Crkl in lung cancer (2000) (0)
horacoscopic Lobectomy Facilitates the Delivery of hemotherapy after Resection for Lung Cancer (2007) (0)
Response. (2020) (0)
MA23.09 Minimally Invasive Approaches Do Not Compromise Outcomes for Pneumonectomy, a Comparison Utilizing the National Cancer Database (2018) (0)
TITLE: Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction RUNNING TITLE: Cerebrospinal Fluid Proteome Changes after Surgery AUTHORS: (2021) (0)
Continue NCCN Clinical Practice Guidelines in Oncology TM Non-Small Cell Lung Cancer (0)
Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults (2021) (0)
Message From the Chair of the NCCN Board of Directors (2012) (0)
Reply: To PMID 23545195. (2014) (0)
Chapter 26 – Mediastinal Tumor (2004) (0)
The Aggressive Cholesterol Therapy to Inhibit Vein Graft Events trial: To continue or not? How to answer the question. (2019) (0)
370 UTILIZATION TRENDS AND VOLUME-OUTCOMES RELATIONSHIP IN ENDOSCOPIC RESECTION FOR STAGE 1 ESOPHAGEAL CANCER IN THE UNITED STATES (2020) (0)
The 12 steps to a thoracoscopic anterior segment segmentectomy: Oncologically safe and sound (2022) (0)
P3.04-013 The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: Topic: Miscellaneous I (2017) (0)
NSCLC Treated at NCCN Institutions With NCCN Guidelines for Patients Diagnosed With Metastatic First-Line Systemic Therapy Practice Patterns and Concordance (2012) (0)
A Phase I Study of UFT/Leucovorin (LV), Carboplatin and Paclitaxel With External Beam Radiation Therapy (EBRT) for Patients With Esophageal Cancer (EC) (2007) (0)
Invited Commentary. (2017) (0)
Response to: "Comment on: A National Analysis of Longterm Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Nonsmallcell Lung Cancer". (2019) (0)
Frozen section of N2 nodes is invaluable whenever unexpected suspicious operative findings are encountered. (2016) (0)
P1.16-39 A Nomogram for Predicting Survival Of TNM8 Stage I Non-Small Cell Lung Cancer Patients to Tailor Potential Chemotherapy Candidates (2018) (0)
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. (2023) (0)
Commentary: Scientists still behaving badly. (2020) (0)
Commentary: Seeking the grail? Choose wisely. (2020) (0)
When should surgeons begin surveillance with CT scans after lobectomy for stage 1A non-small cell lung cancer? (2014) (0)
The Effect of Age on Survival Following Endoscopic Resection vs. Surgery for T1a Esophageal Cancer (2020) (0)
A Delphi Consensus report from the "Prolonged Air Leak: A Survey" study group on prevention and management of postoperative air leaks after minimally invasive anatomical resections. (2022) (0)
Discussion. (2020) (0)
Historical perspectives of The American Association for Thoracic Surgery: Dr David B. Skinner (1935-2003)--a surgeon and something more. (2016) (0)
Comment on "Can Minimally Invasive Esophagectomy Replace Open Esophagectomy for Esophageal Cancer? Latest Analysis of 24,233 Esophagectomies From the Japanese National Clinical Database". (2019) (0)
F-092IMPACT OF PATIENT SELECTION AND TREATMENT STRATEGIES ON OUTCOMES AFTER LOBECTOMY FOR BIOPSY-PROVEN STAGE IIIA pN2 NON-SMALL CELL LUNG CANCER (2015) (0)
China's Opaque Wall of Secrecy. (2022) (0)
Invited commentary. (2007) (0)
CK19 is superior to MUC1 as a marker of micrometastases in patients with non-small cell lung cancer (NSCLC) (2000) (0)
Adjuvant therapies for non-small cell lung cancer: introduction. (2005) (0)
Optimal timing of lobectomy for clinical stage IA non-small cell lung cancer. (2016) (0)
Invited commentary. (2012) (0)
Minimally invasive surgery for “tumor mimicking” foreign body aspiration in an adult (2015) (0)
Association of adjuvant chemotherapy with improved survival after esophagectomy without induction therapy for node-positive adenocarinoma. (2014) (0)
Historical perspectives of The American Association for Thoracic Surgery: Paul A. Ebert (1932-2009). (2015) (0)
Modified Uniportal Approach (2019) (0)
MA08.05 A Multi-Center Analysis of Right vs Left-Sided Pneumonectomy Following Induction Therapy (2019) (0)
A phase I study of capecitabine (CAP), carboplatin (CARB), paclitaxel (TAX) and external beam radiation therapy (EBRT) for patients with esophageal carcinoma (EC). (2006) (0)
Tracheobronchial Stents in Selected Patients with Benign Airway Disease (2004) (0)
Video assisted thoracic surgery with chest wall resection (2018) (0)
The VIOLET Trial: The Final Chapter to this Epic (2023) (0)
Stage and Treatment Migration in Patients With Stage III Non-Small Cell Lung Cancer (2007) (0)
The Impact of Adjuvant Hemithoracic Radiation on Outcomes in Patients With Stage I-III Malignant Pleural Mesothelioma (2021) (0)
Recent randomized trials on stage III lung cancer treatment (2016) (0)
Division of the bronchus: an approach to the intraoperative management of difficult lymphadenopathy. (2016) (0)
Impact of Dissected Lymph Node Count on PD-1 Inhibitors Efficacy in Postoperative Recurred NSCLC: A Multi-Institutional Retrospective Study (2021) (0)
Surgical Aspects of Thoracic Malignancies (2014) (0)
Multiple pulmonary nodules: a management dilemma (2021) (0)
Resection of the irradiated esophagus: the impact of lymph node yield on survival. (2020) (0)
Invited Commentary. (2015) (0)
Thoracoscopic right diaphragm plication by using the endostapling devices and over-sewing (2015) (0)
F-150LONG-TERM SURVIVAL FOLLOWING OPEN VERSUS VIDEO-ASSISTED THORACOSCOPIC LOBECTOMY AFTER INDUCTION THERAPY FOR NON-SMALL CELL LUNG CANCER (2015) (0)
Incorporating into Thoracic Surgery Practice (2011) (0)
Induction Therapy for Clinical Stage I Lung Cancer (2007) (0)
The Impact of Adjuvant Therapy on Survival in Patients with Indeterminate Margins Following Surgery for Non-small Cell Lung Cancer (2020) (0)
Keep moving forward. (2017) (0)
Gastric Cancer NCCN Gastric Cancer Panel Members Continue (2001) (0)
Identification Of An Inflammatory Variant Of Usual Interstitial Pneumonia ("Blue"-Interstitial Pneumonia): Implications For The Prognosis And Treatment Of Idiopathic Interstitial Pneumonia (2012) (0)
Outcomes for locally advanced T1-T3N1M0 esophageal cancer: the impact of traveling to a high volume center for treatment (2014) (0)
Commentary: Trust but verify-How do we keep the faith? (2019) (0)
How to Approach Multifocal Lung Cancer (2018) (0)
GERIATRIC GENERAL THORACIC SURGERY (0)
Troubleshooting hilar and interlobar lymphadenopathy during thoracoscopic lobectomy for benign disease-case report. (2016) (0)
SBRT and Surgery for Stage I NSCLC Are Associated With Comparably Low Rates of Acute Toxicity (2013) (0)
MA12.03 The Impact of Malignant Pleural Mesothelioma Histology on the Use of Surgery and Survival in a Population-Based Analysis (2018) (0)
Historical perspectives of The American Association for Thoracic Surgery: Henry T. Bahnson (1920-2003). (2013) (0)
Perioperative Outcomes and Survival after Preoperative Immunotherapy for Non-small-cell Lung Cancer. (2021) (0)
Commentary: Are we home yet? (2020) (0)
Invited commentary. (2011) (0)
JCOG0802: Another Giant Leap (2022) (0)
Video-Assisted Thoracoscopic Surgery for Mediastinal Lymph Node Dissection (2010) (0)
Visiting an old foe: distant recurrence following R0 lobectomy for pathological N0 lung adenocarcinoma. (2018) (0)
Reply: To PMID 23063200. (2013) (0)
60OThe benchmark of examined lymph node count in node positive NSCLC patients: A populational validation with SEER database (2017) (0)
Japanese Oncology Group 0802: Another giant leap. (2022) (0)
Induction Therapy or Upfront Surgery? The Debate Rages On. (2021) (0)
Molecular and genetic markers in thoracic surgery. (2006) (0)
Metabolic to mechanical energy transfer after regional and global myocardial ischemia (1991) (0)
Response to (2018) (0)
GR 03.03 Thoracoscopic Segmentectomy for Early-Stage Lung Cancer (2017) (0)
Invited Commentary. (2015) (0)
Invited commentary. (2006) (0)
Comprar The Biology of Thoracic Surgery: Innovations in Staging and Treatment, An Issue of Thoracic Surgery Clinics,16-4 | Thomas D'Amico | 9781416047865 | Saunders (2007) (0)
Comparative Effectiveness of 5 Local-Regional Control Strategies for IIIA (N2) Non-small Cell Lung Cancer Using SEER Data: Outcomes After Treatment of 20,468 Patients (2016) (0)
The Effect of Increasing Experience with Intensity Modulated Radiation Therapy for Resected Malignant Pleural Mesothelioma (2010) (0)
VATS – CONVENTIONAL APPROACH (2013) (0)
PD-095 Monitoring tumor markers in serial sera predicts disease failurein lung cancer patients following surgery (2005) (0)
Immune profiling of circulating T cells and TILs following neoadjuvant ipilimumab and chemotherapy in non-small cell lung cancer (NSCLC). (2017) (0)
The Video-Assisted Thoracoscopic or Open Lobectomy (VIOLET) trial: The final chapter to this epic. (2023) (0)
Growth and Change at NCCN. (2015) (0)
Commentary: Inside out (2021) (0)
P1.16-50 The Role of Adjuvant Therapy for Patients with Early Stage Large Cell Neuroendocrine Lung Cancer: A National Analysis (2018) (0)
MA05.03 Impact of Time to Surgery on Outcomes in Patients Undergoing Outright Resection for Malignant Pleural Mesothelioma (2019) (0)
Multi-Institutional Care in Clinical Stage II and III Esophageal Cancer. (2022) (0)
P3.07-012 Disparities in Guideline-Concordant Treatment for Node-positive Non-Small Cell Lung Cancer Following Surgery: Topic: Other – Geographical Differences (2017) (0)
Preface to the book This is life: the journey of uniportal VATS (2016) (0)
Design of interventional studies in thoracic surgery. (2017) (0)
Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival (2017) (0)
Comparative Effectiveness of Stereotactic Radiosurgery (SRS) Versus Whole Brain Radiation Therapy (WBRT) for Patients With Brain Metastases From Non-Small Cell Lung Cancer (NSCLC) (2013) (0)
Reply to T.-H. Wang et al. (2017) (0)
Invited commentary. (2011) (0)
Non-small cell lung cancer. (2008) (0)
An e-score is born. (2015) (0)
Implementing genomically-guided trials in non-small cell lung carcinoma (NSCLC). (2010) (0)
Monitoring tumor markers in serial sera predicts disease failure in lung cancer patients following surgery (2005) (0)
F-084PERFORMING SLEEVE LOBECTOMY INSTEAD OF PNEUMONECTOMY FOR NON-SMALL LUNG CANCER WITH N1 NODAL DISEASE DOES NOT COMPROMISE LONG-TERM SURVIVAL (2013) (0)
Original articleGeneral thoracicInvited commentary (2007) (0)
P2.06-03 Timing of Surgery After Induction Therapy for Malignant Pleural Mesothelioma: A National Analysis (2019) (0)
Patterns of Care in Neoadjuvant Chemoradiotherapy for Node Positive Esophageal Adenocarcinoma. (2020) (0)
SC01.05 Video-Thoracoscopy for Staging of N2 NSCLC During Induction Therapy (2017) (0)
Thoracoscopic lobectomy was introduced without the support of prospective randomized trials; however, the advantages of thoracoscopic lobectomy were demonstrated through multi-institutional and propensity-matched studies, proving the quality of life advantages, safety advantages, and cost advantages (2010) (0)
Discussion. (2020) (0)
Videothoracoscop ic Mediastinal (2010) (0)

This paper list is powered by the following services:

Thomas Anthony D’amico's Academic­Influence.com Rankings

Why Is Thomas Anthony D’amico Influential?

Thomas Anthony D’amico's Published Works

Published Works

Thomas Anthony D’amico's AcademicInfluence.com Rankings